Bionics Market Size and Share
Market Overview
| Study Period | 2020 - 2031 |
|---|---|
| Market Size (2026) | USD 8.02 Billion |
| Market Size (2031) | USD 12.62 Billion |
| Growth Rate (2026 - 2031) | 9.48% CAGR |
| Fastest Growing Market | Asia-Pacific |
| Largest Market | North America |
| Market Concentration | Low |
Major Players *Disclaimer: Major Players sorted in no particular order Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0. | |
Bionics Market Analysis by Mordor Intelligence
The Bionics market size is expected to grow from USD 7.33 billion in 2025 to USD 8.02 billion in 2026 and is forecast to reach USD 12.62 billion by 2031 at 9.48% CAGR over 2026-2031.
COVID-19 negatively impacted the bionics market. The pandemic caused added challenges for patients who are having some form of disabilities and organ failures. Due to social distancing, many hospitals were restricted to non-elective procedures and surgeries, and they were instead offering patients video conferencing with disabilities to overcome the limitations of the market growth. For instance, according to the research study published in September 2021 by Harper L. Wilson et al., during the COVID-19 pandemic, adult users of cochlear implants and people living in rural areas faced greater difficulties, including pandemic preparedness and access to healthcare, which has a detrimental effect on the market under study. However, the market under study is anticipated to reach its full potential over the forecast period due to ongoing vaccinations and a decline in COVID-19 cases.
Factors that are responsible for the growth of the market include increased incidence of disabilities and organ failures, technological advancements, and high incidence of road accidents leading to amputations. For instance, as per the data published by the World Health Organization in October 2021, approximately 2.2 billion people were affected with blindness or vision impairment, out of which at least 1 billion people had unaddressed or preventable conditions worldwide. Moreover, in 2020, there are 2.6 billion myopic individuals of all ages. Age-related macular degeneration has affected 195.6 million people between the ages of 30 and 97 in 2020. Thus the increasing prevalence of targeted disabilities, the market is likely to grow at a faster pace in upcoming years.
Another primary factor is the scarcity of donor organs. The lack of availability of potential organs to transplant has been a major issue. The demand for organ donors is increasing and is very high compared to the actual supply. Bionics are able to cater to the needs of those in need of organ transplantations and replacements. It can replicate the function of damaged organs. The replication is almost the same. This level of scarcity of organs has turned into a boon for artificial organs and the bionics industry.
Rising product approval and technological advancement in this industry are also likely to fuel the market growth in upcoming years. For instance, in 2020, Edwards Lifesciences Corporation announced that its KONECT RESILIA aortic valved conduit (AVC) received approval from the United States Food and Drug Administration (FDA) as the first ready-to-implant solution for bio-Bentall procedures. Additionally, in March 2020, Widex launched the Moment hearing device. The Widex Moment has the 'classic' Widex signal pathway, which is paired with a second ultra-fast signal pathway that adds extra gearing to the platform.
However, the factors such as the fear of device malfunction and its consequences, high cost of devices, and uncertain reimbursement scenarios, among others, may impact market growth.
Note: Market size and forecast figures in this report are generated using Mordor Intelligence’s proprietary estimation framework, updated with the latest available data and insights as of 2026.
Global Bionics Market Trends and Insights
Cochlear implant are Estimated to Hold a Significant Share in the Fixation Type Segment of the Bionics Market
The cochlear implant performs the function of damaged cochlea parts by transmitting the electrical signals to the brain, converting sound into electrical signals, and restoring hearing. People with mild to severe hearing loss use it as hearing bionics.
Due to their affordability, cochlear implants are highly favored. For instance, according to a research study titled "Cost-benefit Analysis of Cochlear Implants: A Societal Perspective" published in PubMed, in March 2021, concluded that the adults and seniors with unilateral cochlear implantation (CI) and progressive severe hearing loss had a net economic benefit of EUR 275,000 and EUR 76,000, respectively. Even without taking health benefits into account, children and those in the workforce, in particular, benefited from the societal impact.
In the upcoming years, market growth is anticipated to be aided by the older population's relatively high burden of hearing impairment. For instance, a research study titled "Association of Age-Related Hearing Impairment With Physical Functioning Among Community-Dwelling Older Adults in the US" published in JAMA Network, in June 2021, a population-based cohort study involving 2,956 older Americans found that 973 (33%) had normal hearing, 1,170 (40%) had mild hearing impairment, 692 (23%) had moderate impairment, and 121 (4%) had a severe impairment. As a result, it is anticipated that the demand for cochlear implants will rise along with the population of elderly people.
The key market players' introduction of technologically advanced products, however, support the market's expansion. For instance, in January 2022, Cochlear Limited, obtained United States Food and Drug Administration (U.S. FDA) approval for Cochlear Nucleus Implants for the treatment of unilateral hearing loss (UHL) or single-sided deafness (SSD).
The segment is therefore anticipated to experience significant growth over the course of the forecast period as a result of the factors listed above.
North America Dominates the Market and is Expected to Do Same During the Forecast Period
Currently, North America dominates the market for bionics, and it is expected to continue its stronghold for a few more years. In the North American region, the United States holds the largest market share. The rising prevalence of chronic diseases and increasing demand for non-invasive surgical procedures are helping in the dominance of the North American region in the bionics market.
The disabled community around the region is affected especially hard by the COVID-19 pandemic. Coronavirus lockdown has made life especially tough for the region's disabled population, such as people having the vision, hearing impaired population. Thus, in countries, such as the United States, in 2020, the Disability Inclusion Fund (DIF) announced the launch of a USD 200,000 rapid response fund to support the needs of people with disabilities related to the impact of COVID-19.
According to the report of Statistics Canada published in October 2021, Overall, audiometrically measured hearing loss, tinnitus, or both conditions affected 60% of Canadians between the ages of 19 and 79. Men were more likely than women to experience hearing loss and tinnitus. Furthermore, North America's bionics market is anticipated to be dominated by the United States during the forecast period due to the country's high incidence and prevalence of hearing loss as well as its widespread use of hearing bionics. According to the March 2021 update from the National Institute on Deafness and Other Communication Disorders, in the United States, 2 to 3 out of every 1,000 newborns have a detectable level of hearing loss in one or both ears, and 15% of adults (18 and older) in the country (37.5 million) report having some hearing issues in 2020.
The presence of developed healthcare infrastructure and major market players focussing on various market strategies so as to gain a competitive edge is also expected to propel the market. in November 2021, Advanced Bionics (AB), received Health Canada approval and announces it is bringing Marvel hearing technology to Advanced Bionics cochlear implant wearers. This includes: New Naída CI Marvel sound processor for adults, New Advanced Bionics Remote app for easy adjustments via smartphone, and others. The software provides real-time feedback to the surgeon to guide the insertion placement.
Thus, due to the factors mentioned above, the segment is expected to witness significant growth over the forecast period.
Competitive Landscape
The bionics market is moderately competitive and consists of various major players. In terms of market share, some of the major players currently dominate the bionics market. Owing to the rising adoption of medical bionics and an increasing number of people in need of organs, few other smaller players are expected to enter the market. Some of the major players of the market are Medtronic PLC, Edward Lifesciences Corporation, Ekso Bionics, and Ossur (Touch Bionics), among others.
Bionics Industry Leaders
Medtronic PLC
Edward Lifesciences Corporation
Advanced Bionics AG
Ekso Bionics
Ossur (Touch Bionics)
- *Disclaimer: Major Players sorted in no particular order
Market Opportunities and Future Outlook
Commercial activity is expanding the addressable use cases for bionics beyond traditional implantables and limb prosthetics, with traction in active hearing implants, robotic exoskeletons, and neurotechnology. In July 2026, Cochlear received FDA clearance for the Osia 3 Sound Processor, which supports rechargeable active bone-conduction systems as an upgrade path for patients and clinics already operating with active implant workflows. In orthopedics, Ottobock introduced the dynion explore hydraulic prosthetic knee joint at its OTWorld 2026 world premiere, pointing to a gap in adolescent-specific mobility solutions that bridge pediatric and adult prosthetic needs.
A second opportunity lane is the expanding pipeline for brain-computer interface (BCI) enabled neuroprosthetics and sensory restoration programs progressing through clinical pathways. BCIIntel cited multiple concurrent pivotal and IDE-stage efforts in 2026, including enrollment activity for Paradromics Connect-One at the University of Michigan for speech restoration, alongside high-profile visual prosthesis work such as Neuralink's first-in-human Blindsight implant. These programs drive demand for enabling components and services across implant hardware, neural decoding software, and long-term biocompatibility. At the same time, consumer-facing exoskeleton launches and funding rounds, including Hypershell's X Series and Series B+ financing, broaden market activity beyond clinical mobility augmentation use cases.
Recent Industry Developments
- May 2026: ChronoScale Corporation's Board approved a plan to divest its wholly owned subsidiary, Ekso Bionics. The announcement points to restructuring around exoskeleton and rehabilitation robotics assets, with implications for commercialization priorities and partner arrangements across clinical and industrial bionics solutions.
- April 2026: Advanced Bionics announced an equity investment and research collaboration with Spiral Therapeutics to explore drug-delivery platforms in the context of cochlear implant surgery. The collaboration highlights interest in pairing implantable bionics with adjunct therapeutics, which could broaden differentiation in hearing bionics and post-surgical care pathways.
- April 2024: Medtronic announced CE Mark for the Stealth AXiS surgical system. Wider availability of advanced navigation and integrated surgical platforms can support adoption of complex implant procedures by standardizing workflows and improving procedural confidence in hospitals.
Research Methodology Framework and Report Scope
Market Definition and Coverage
For this study, the bionics market covers artificial devices that are implanted or integrated into the human body to replace a lost function or support a natural function, and the related systems used for functional restoration.
Scope exclusions: Non-medical enhancement gadgets and general wearables that are not designed to restore a human function are not counted.
Segmentation Overview
- Type of Bionics
- Vision Bionics
- Ear Bionics
- Cochlear Implant
- Bone-anchored Hearing Aid (BAHA)
- Orthopedic Bionic
- Bionic Hand
- Bionic Leg
- Cardiac Bionics
- Heart Valves
- Ventricular-assisted Device
- Pacemaker
- Other Cardiac Bionics
- Fixation
- Implantable Bionics
- External Bionics
- Geography
- North America
- United States
- Canada
- Mexico
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- Middle-East and Africa
- GCC
- South Africa
- Rest of Middle-East and Africa
- South America
- Brazil
- Argentina
- Rest of South America
- North America
Data Sources, Market Sizing, and Validation
Desk Research
Desk work started with public, non-paywalled references to map the demand pool and the clinical adoption signals that drive device uptake. Sources used include, such as the World Health Organization for disability context, Centers for Disease Control and Prevention style public health statistics, and OECD health indicators to understand treatment access and procedure trends.
To ground technology and pipeline direction, we also reviewed sources such as the United States Patent and Trademark Office patent records, peer-reviewed medical engineering journals, and medical device safety and approval communications from regulators. Company annual reports, investor decks, and reputed press were used to sanity-check product mix shifts and regional expansion plans, and a paid subscription for company financials and a patent database helped fill gaps where public disclosures were thin. These desk research sources are illustrative only, and many other references were used for data collection, cross-checks, and clarification.
Primary Interviews and Surveys
Fieldwork was used to pressure-test assumptions that are easy to overstate in bionics, such as eligible patient pools, replacement cycles, and the real-world share of implantable versus external solutions. We spoke with a mix of device-side leaders, clinical and rehab stakeholders, and channel participants across major regions so pricing ladders, procedure-linked volumes, and adoption barriers could be aligned with what is seen in practice.
Distribution of primary research fieldwork respondents
| Company type | Respondent position | Region |
|---|---|---|
| Top tier: 28% | CXOs: 20% | APAC: 41% |
| Mid tier: 50% | Functional/Unit leaders: 27% | EMEA: 36% |
| Smaller Players: 22% | Managers: 53% | Americas: 23% |
Market-Sizing & Forecasting
Sizing was built using top-down and bottom-up logic, where procedure and patient-need signals were first reconstructed by region and then translated into device demand using penetration and replacement assumptions. In practice, this meant building a demand pool from indicators like amputation incidence, hearing loss treatment rates, implant procedure volumes, and rehab access, and then applying device adoption and average selling price ranges to estimate value.
Those totals were then corroborated with selective bottom-up approximations, such as sampling product-level price points, checking typical upgrade cycles, and rolling up a limited set of supplier and channel checks to see if volumes and value are directionally consistent. Inputs that materially move the model include the implantable share versus external share, reimbursement coverage and out-of-pocket mix, component cost and pricing progression, and regional capacity to perform specialized procedures. For forecasting, scenario analysis was used around adoption speed and pricing changes, with near-term trends adjusted using expert views so the curve does not jump unrealistically. When a sub-segment had weak visibility, we used conservative penetration bands and then rechecked the implied installed base against replacement demand before finalizing.
Data Validation & Update Cycle
Model outputs were checked against independent signals like procedure growth rates, import and production cues where available, and reported shifts in device mix from public disclosures. Outliers were flagged, reviewed, and corrected through multi-step analyst checks, and follow-up calls were triggered when a key assumption, such as pricing or implant adoption, changed the totals meaningfully.
The report is refreshed annually, and interim updates are made when material events occur, such as major regulatory actions or sharp pricing moves. Before delivery, a final review pass is completed so the latest public information and field feedback are reflected in the numbers.
Mordor Intelligence's Bionics Market Size Measured Against Other Published Estimates
Published market sizes for bionics can vary quite a bit because the scope line is not the same across sources, and the counting method can shift between device-only value and broader service-linked value. Differences also show up when one estimate assumes faster adoption of high-priced implants, or when currency timing and inflation handling are not consistent.
The main gap comes from whether rehabilitation services and fitting or customization revenues are counted alongside devices, and Mordor Intelligence treats the market as bionics devices integrated or implanted to restore function rather than a full bundled service economy. Another common driver is the demand anchor, where some estimates lean on manufacturer-level sales definitions, while others build from procedure-led volumes and penetration rates, which can lower the near-term value if capacity constraints are recognized.
Benchmark comparison
| Source | Market Size | Gaps in Research Methodology |
|---|---|---|
| Mordor Intelligence | USD 7.33 B (2025) | |
| Industry Research Publisher A | USD 9.28 B (2025) | Uses a broader product basket that explicitly includes exoskeletons and a wider end-use lens, which can lift totals when hospital and home-care demand is modeled more aggressively. |
| Global Research Publisher B | USD 14.90 B (2025) | Counts device revenues together with related services like rehab support and fitting, and applies a factory-gate valuation approach that can enlarge the reported market versus a device-focused scope. |
Overall, the spread is mainly explained by what is counted as market revenue and which demand signal is used to scale volumes and pricing. By keeping the steps traceable to procedure-linked uptake and clear device inclusions, the estimate stays easier to reproduce and compare year to year, even when growth assumptions change.
Key Questions Answered in the Report
How big is the Global Bionics Market?
The Global Bionics Market size is expected to reach USD 8.02 billion in 2026 and grow at a CAGR of 9.48% to reach USD 12.62 billion by 2031.
What is the current Global Bionics Market size?
In 2026, the Global Bionics Market size is expected to reach USD 8.02 billion.
Who are the key players in Global Bionics Market?
Medtronic PLC, Edward Lifesciences Corporation, Advanced Bionics AG, Ekso Bionics and Ossur (Touch Bionics) are the major companies operating in the Global Bionics Market.
Which is the fastest growing region in Global Bionics Market?
Asia-Pacific is estimated to grow at the highest CAGR over the forecast period (2026-2031).
Which region has the biggest share in Global Bionics Market?
In 2025, the North America accounts for the largest market share in Global Bionics Market.
What years does this Global Bionics Market cover, and what was the market size in 2025?
In 2025, the Global Bionics Market size was estimated at USD 7.33 billion. The report covers the Global Bionics Market historical market size for years: 2019, 2020, 2021, 2022, 2023, 2024 and 2025. The report also forecasts the Global Bionics Market size for years: 2026, 2027, 2028, 2029, 2030 and 2031.
Page last updated on:
